Alergologia Polska - Polish Journal of Allergology

Abstract

3/2020 vol. 7
Review paper

Vaccine against COVID-19 or against SARS-CoV-2 infection?

Piotr Rieske 1, 2
  1. Zakład Biologii Nowotworów, Uniwersytet Medyczny w Łodzi
  2. Celther Polska
Alergologia Polska – Polish Journal of Allergology 2020; 7, 3: 131–145
DOI: https://doi.org/10.5114/pja.2020.97913
Online publish date: 2020/08/05
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine – showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.

Keywords

SARS-CoV-2, vaccine, COVID-19

Share
without publication fees
Coverage in
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications